3-[(2-环己基-2-羟乙基)氨基]-2,5-二氧代-1-(苯甲基)-4-咪唑啶庚酸结构式
|
常用名 | 3-[(2-环己基-2-羟乙基)氨基]-2,5-二氧代-1-(苯甲基)-4-咪唑啶庚酸 | 英文名 | BW A868C |
|---|---|---|---|---|
| CAS号 | 118675-50-6 | 分子量 | 459.578 | |
| 密度 | 1.2±0.1 g/cm3 | 沸点 | 638.1±65.0 °C at 760 mmHg | |
| 分子式 | C25H37N3O5 | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 339.7±34.3 °C |
用途BW A868C是乙内酰脲化合物,是BW245C结构类似物。BW A868C是一种选择性和有效的竞争性前列腺素D2(PGD2)拮抗剂。BW A868C对其他前列腺素受体(IP、EP1、EP2、TP和FP)没有影响[1]。 |
| 中文名 | 3-[(2-环己基-2-羟乙基)氨基]-2,5-二氧代-1-(苯甲基)-4-咪唑啶庚酸 |
|---|---|
| 英文名 | 7-[1-benzyl-3-[(2-cyclohexyl-2-hydroxyethyl)amino]-2,5-dioxoimidazolidin-4-yl]heptanoic acid |
| 英文别名 | 更多 |
| 描述 | BW A868C是乙内酰脲化合物,是BW245C结构类似物。BW A868C是一种选择性和有效的竞争性前列腺素D2(PGD2)拮抗剂。BW A868C对其他前列腺素受体(IP、EP1、EP2、TP和FP)没有影响[1]。 |
|---|---|
| 相关类别 | |
| 靶点实验 |
PGD2 |
| 体外研究 | BW A868C拮抗前苷元D2和BW245C诱导的人血小板腺苷酸环化酶激活[1]。 |
| 参考文献 |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 沸点 | 638.1±65.0 °C at 760 mmHg |
| 分子式 | C25H37N3O5 |
| 分子量 | 459.578 |
| 闪点 | 339.7±34.3 °C |
| 精确质量 | 459.273315 |
| PSA | 110.18000 |
| LogP | 3.31 |
| InChIKey | YZJVWSKJHGEIBL-UHFFFAOYSA-N |
| SMILES | O=C(O)CCCCCCC1C(=O)N(Cc2ccccc2)C(=O)N1NCC(O)C1CCCCC1 |
| 蒸汽压 | 0.0±2.0 mmHg at 25°C |
| 折射率 | 1.593 |
| 个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| 危险品运输编码 | NONH for all modes of transport |
| WGK德国 | 3 |
|
Multiplexed phosphospecific flow cytometry enables large-scale signaling profiling and drug screening in blood platelets.
J. Thromb. Haemost. 12(10) , 1733-43, (2014) Dissecting the signaling events that contribute to platelet activation will increase our understanding of platelet function and aid in the development of new antiplatelet agents. However, high-through... |
|
|
Genetic validation of a therapeutic target in a mouse model of ALS.
Sci. Transl. Med. 6(248) , 248ra104, (2014) Neurons produced from stem cells have emerged as a tool to identify new therapeutic targets for neurological diseases such as amyotrophic lateral sclerosis (ALS). However, it remains unclear to what e... |
|
|
Pro-migratory actions of the prostacyclin receptor in human breast cancer cells that over-express cyclooxygenase-2.
Biochem. Pharmacol. 96 , 306-14, (2015) Metastasis is the major cause of death in cancer patients. Elevated expression of cyclooxygenase-2 (COX-2) is observed in many human cancers and over-production of downstream prostaglandins (PGs) has ... |
|
实验名称:Discovery of Small Molecules to Inhibit Human Cytomegalovirus Nuclear Egress
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:HCMV UL50
External Id:HMS1262
|
|
实验名称:Mouse DP1 receptor (Prostanoid receptors)
来源:IUPHAR-DB
靶标:DP1 receptor (Prostanoid receptors) [Mus musculus]
External Id:338_Mouse
|
|
实验名称:A screen for small molecules that modulate mitochondrial supercomplex formation
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:N/A
External Id:HMS1482
|
|
实验名称:Human DP1 receptor (Prostanoid receptors)
来源:IUPHAR-DB
靶标:DP1 receptor (Prostanoid receptors) [Homo sapiens]
External Id:338_Human
|
|
实验名称:Cell-based high throughput primary assay to identify activators of GPR151
来源:The Scripps Research Institute Molecular Screening Center
靶标:RecName: Full=G-protein coupled receptor 151; AltName: Full=G-protein coupled receptor PGR7; AltName: Full=GPCR-2037; AltName: Full=Galanin receptor 4; AltName: Full=Galanin-receptor-like protein; Short=GalRL
External Id:GPR151_PHUNTER_AG_LUMI_1536_1X%ACT
|
|
实验名称:AlphaScreen-based biochemical high throughput primary assay to identify inhibitors of...
来源:The Scripps Research Institute Molecular Screening Center
External Id:MITF_INH_Alpha_1536_1X%INH PRUN
|
|
实验名称:Stabilization of p53 in human papillomavirus-positive cells
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:Cellular tumor antigen p53
External Id:HMS1485
|
|
实验名称:Discovering small molecule activators of G protein-gated inwardly-rectifying potassiu...
来源:15621
靶标:G protein-activated inward rectifier potassium channel 2
External Id:VANDERBILT_HTS_GIRK2_MPD
|
| BW A868C |
| 3-[(2-Cyclohexyl-2-hydroxyethyl)amino]-2,5-dioxo-1-(phenylmethyl)- 4-imidazolidineheptanoic acid |
| 7-{1-Benzyl-3-[(2-cyclohexyl-2-hydroxyethyl)amino]-2,5-dioxo-4-imidazolidinyl}heptanoic acid |
| 7-{1-Benzyl-3-[(2-cyclohexyl-2-hydroxyethyl)amino]-2,5-dioxoimidazolidin-4-yl}heptanoic acid |